Next month will mark my 5th year as an AMBS shareholder. It's been a long journey, but I'm hopeful that 2018 will bring the turnaround many patients and investors have been waiting on.
(1)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
